Evolution and development of potent monobactam sulfonate candidate IMBZ18g as a dual inhibitor against MDR Gram-negative bacteria producing ESBLs.
Li Z, Guo Z, Lu X, Ma X, Wang X, Zhang R, Hu X, Wang Y, Pang J, Fan T, Liu Y, Tang S, Fu H, Zhang J, Li Y, You X, Song D.
Li Z, et al. Among authors: tang s.
Acta Pharm Sin B. 2023 Jul;13(7):3067-3079. doi: 10.1016/j.apsb.2023.03.002. Epub 2023 Mar 7.
Acta Pharm Sin B. 2023.
PMID: 37521870
Free PMC article.